Capula Management LTD Incyte Corp Transaction History

Capula Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $176,683 - $221,209	2,630 New	2,630 $211,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $345,266 - $403,973	-5,451 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $29,253 - $35,792	-426 Reduced 7.25%	5,451 $375,000
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $469,395 - $514,413	5,877 New	5,877 $494,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.